Federal grants
Grants.gov index · last synced Aug 13 at 9:12 AM
1,114 open542 forecasted
1,656 grants
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
Closes Nov 16, 2027National Institutes of Health
GrantALN 93.865PAR-25-265 · Posted Dec 2, 2024Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)
Closes Nov 16, 2027National Institutes of Health
GrantALN 93.847PAR-25-068 · Posted Jan 8, 2025Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
Closes Nov 16, 2027National Institutes of Health
GrantALN 93.393PAR-25-244 · Posted Nov 18, 2024Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)
Closes Nov 18, 2027National Institutes of Health
GrantALN 93.839Up to $300,000RFA-DA-26-034 · Posted Nov 20, 2024DEVCOM ARMY RESEARCH LABORATORY BROAD AGENCY ANNOUNCEMENT FOR FOUNDATIONAL RESEARCH
Closes Nov 20, 2027Dept of the Army -- Materiel Command
GrantALN 12.431W911NF-23-S-0001 · Posted Nov 21, 2022Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
Closes Dec 3, 2027National Institutes of Health
GrantALN 93.273RFA-DA-26-056 · Posted Dec 5, 2024Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
Closes Dec 3, 2027National Institutes of Health
GrantALN 93.273RFA-DA-26-055 · Posted Dec 5, 2024Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)
Closes Dec 23, 2027National Institutes of Health
GrantALN 93.837RFA-HL-26-019 · Posted Nov 22, 2024Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)
Closes Dec 23, 2027National Institutes of Health
GrantALN 93.839RFA-HL-26-020 · Posted Nov 22, 2024Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
Closes Dec 23, 2027National Institutes of Health
GrantALN 93.839Up to $350,000RFA-HL-26-016 · Posted Nov 22, 2024Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
Closes Dec 23, 2027National Institutes of Health
GrantALN 93.838RFA-HL-26-017 · Posted Nov 22, 2024Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)
Closes Dec 23, 2027National Institutes of Health
GrantALN 93.855RFA-HL-26-018 · Posted Nov 22, 2024NPS Cooperative Ecosystems Studies Units (CESU) Master Cooperative Agreements
Closes Dec 31, 2027National Park Service
GrantALN 15.945Up to $0P23AS00132 · Posted Dec 22, 2022CONTAMINATED ALASKA NATIVE CLAIMS SETTLEMENT ACT LANDS ASSISTANCE PROGRAM
Closes Dec 31, 2027Environmental Protection Agency
GrantALN 66.965Up to $3,000,000EPA-OLEM-R10-NC-24-01 · Posted Dec 28, 2023DEVCOM ANALYSIS CENTER BROAD AGENCY ANNOUNCEMENT FOR APPLIED RESEARCH
Closes Jan 4, 2028Dept of the Army -- Materiel Command
GrantALN 12.431W911NF-23-S-0003 · Posted Jan 5, 2023NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Closes Jan 6, 2028National Institutes of Health
GrantALN 93.121PAR-25-057 · Posted Oct 23, 2024Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)
Closes Jan 6, 2028National Institutes of Health
GrantALN 93.121PAR-25-062 · Posted Oct 10, 2024NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Closes Jan 6, 2028National Institutes of Health
GrantALN 93.121Up to $500,000PAR-25-188 · Posted Dec 2, 2024Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
Closes Jan 6, 2028National Institutes of Health
GrantALN 93.839PAS-25-205 · Posted Nov 6, 2024Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
Closes Jan 7, 2028National Institutes of Health
GrantALN 93.839Up to $375,000PAR-25-298 · Posted Dec 6, 2024Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)
Closes Jan 7, 2028National Institutes of Health
GrantALN 93.853PAR-25-024 · Posted Oct 28, 2024Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
Closes Jan 7, 2028National Institutes of Health
GrantALN 93.396PAR-25-148 · Posted Nov 21, 2024Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
Closes Jan 7, 2028National Institutes of Health
GrantALN 93.393Up to $500,000PAR-25-175 · Posted Nov 6, 2024Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)
Closes Jan 7, 2028National Institutes of Health
GrantALN 93.393PAR-25-044 · Posted Sep 5, 2024Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
Closes Jan 7, 2028National Institutes of Health
GrantALN 93.847Up to $75,000PAR-25-091 · Posted Jan 10, 2025